SCHEMBL6728722

SCHEMBL6728722

CCOc1ccc2[nH]cc(C(=O)O)c2n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.44
PRKAG1 P54619 3/20 0.43
PRKAA1 Q13131 3/20 0.43
PRKAB1 Q9Y478 3/20 0.43
PRKAB2 O43741 1/20 0.43
PRKAA2 P54646 1/20 0.43
PRKAG3 Q9UGI9 1/20 0.43
PRKAG2 Q9UGJ0 1/20 0.43
HTT P42858 1/20 0.42
MTNR1A P48039 1/20 0.41
MTNR1B P49286 1/20 0.41
KDM4E B2RXH2 5/20 0.40
ALDH1A1 P00352 3/20 0.40
HPGD P15428 3/20 0.40
HSD17B10 Q99714 3/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
CYP1A2 P05177 2/20 0.40
TSHR P16473 1/20 0.40
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6448287 0.91 HTT (0.48) MAPTPRKAG1PRKAA1PRKAB1PRKAB2
SCHEMBL6734102 0.85 PRKAG1 (0.46) MAPTPRKAG1PRKAA1PRKAB1PRKAB2
SCHEMBL6722059 0.84 ALDH1A1 (0.43) MAPTHTTMTNR1AMTNR1BKDM4E
SCHEMBL6667683 0.84 MTNR1A (0.53) PRKAG1PRKAA1PRKAB1PRKAB2PRKAA2
SCHEMBL30267364 0.84 MTNR1A (0.53) PRKAG1PRKAA1PRKAB1PRKAB2PRKAA2
SCHEMBL6724529 0.83 PIM1 (0.41) MAPTHTTMTNR1AMTNR1BKDM4E
SCHEMBL6722084 0.83 PIM1 (0.48) MAPTHTTMTNR1AMTNR1BKDM4E
SCHEMBL6726958 0.82 KDM4E (0.39) MAPTPRKAG1PRKAA1PRKAB1PRKAB2
SCHEMBL6729681 0.82 PIM1 (0.43) MAPTHTTMTNR1AMTNR1BKDM4E
SCHEMBL6389885 0.80 GABRA1 (0.54) KDM4EALDH1A1HPGDHSD17B10CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6673811-B1 TREATMENT OF ANXIETY, DEPRESSION, SLEEP DISORDER, ATTENTION DEFICIT DISORDER, ALZHEIMER'S DEMENTIA, OR SHORT-TERM MEMORY LOSS NEUROGEN CORPORATION 2004-01-06 US claimed
US-6673811-B1 TREATMENT OF ANXIETY, DEPRESSION, SLEEP DISORDER, ATTENTION DEFICIT DISORDER, ALZHEIMER'S DEMENTIA, OR SHORT-TERM MEMORY LOSS NEUROGEN CORPORATION 2004-01-06 US disclosed